OCUGEN INC OCGN 深 滬
等待開盤 06-25 09:30:00 美东时间
1.39
+0.010
+0.72%
華盛通- 最 高1.47
- 今 開1.37
- 成交量 653.21万股
- 最 低 1.365
- 昨 收 1.38
- 總市值 4.71亿
- 52周最高 2.725
- 市盈率 靜 --
- 換手率 1.93%
- 52周最低 0.9085
- 委 比 -71.30%
- 總股本 3.39亿
- 歷史最高 18.77
- 量 比 0.60
- 振 幅 7.61%
- 歷史最低 0.17
- 每 手 1
- 風險率 0.32%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Definium Therapeutics launches $500M public offering
Definium Therapeutics (DFTX) announced plans for an underwritten public offering of $500M of common shares and, for certain investors, pre-funded warrants. Definium also intends to grant underwriters ...
06-23 04:08
Nasdaq, Take-Two, Fastly, Ocugen, Sony Insider Shock
Insiders have been trading these 5 stocks: (($NDAQ)), (($TTWO)), (($FSLY)), (($...
06-20 21:01
Ocugen Stockholders Approve Proposals and Confirm Leadership
An update from Ocugen ( ($OCGN) ) is now available. On June 11, 2026, Ocugen he...
06-12 06:56
CytomX gains as licensing deal with Regeneron expands
CytomX Therapeutics (CTMX) traded higher in the morning hours on Wednesday after the cancer drug developer announced an expanded collaboration and licensing agreement with Regeneron Pharmaceuticals (R...
06-03 21:52
美股大行评级 | 潜在涨幅99.91%！Tigress Financial上调英伟达目标价至425美元，维持"强力买入"评级
今日重点评级关注：Tigress Financial：维持英伟达"强力买入"评级，目标价从360美元升至425美元；康托·菲茨杰拉德：维持DeFi Development"超配"评级，目标价从6美元升至7美元
05-28 19:00
Canaccord Genuity Maintains Buy on Ocugen, Lowers Price Target to $11
Canaccord Genuity analyst Whitney Ijem maintains Ocugen (NASDAQ:OCGN) with a Buy and lowers the price target from $12 to $11.
05-27 20:51
Ocugen Advances Late-Stage Gene Therapies, Bolsters Cash Runway
Ocugen ( ($OCGN) ) just unveiled an announcement. Ocugen, Inc., based in Malver...
05-05 23:58
Ocugen stock dips as Q1 losses widen
Ocugen (OCGN) shares fell over 19% on Tuesday after the biotech’s net losses widened in Q1. Net loss for the quarter was $19.17M, compared to a $15.35M loss in the same period last year. The increased...
05-05 23:43
Full Transcript: Ocugen Q1 2026 Earnings Call
Ocugen (NASDAQ:OCGN) reported first-quarter financial results on Tuesday. The t...
05-05 23:11
Ocugen Q1 EPS $(0.06) Misses $(0.05) Estimate, Sales $1.533M Beat $540.000K Estimate
Ocugen (NASDAQ:OCGN) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $(0.05) by 20 percent. This is a 20 percent decrease over losses of $(0.05) per share from the same
05-05 20:40
